Cheng et al., 2023 - Google Patents

Targeting lung–gut axis for regulating pollution particle–mediated inflammation and metabolic disorders

Cheng et al., 2023

View HTML
Document ID
3512055438208709234
Author
Cheng T
Chang C
Luo C
Chen K
Yeh Y
Zheng J
Wu S
Publication year
Publication venue
Cells

External Links

Snippet

Cigarette smoking (CS) or ambient particulate matter (PM) exposure is a risk factor for metabolic disorders, such as insulin resistance (IR), increased plasma triglycerides, hyperglycemia, and diabetes mellitus (DM); it can also cause gut microbiota dysbiosis. In …
Continue reading at www.mdpi.com (HTML) (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Micro-organisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/02—Algae
    • A61K36/05—Chlorophycota or chlorophyta (green algae), e.g. Chlorella

Similar Documents

Publication Publication Date Title
Wang et al. Lactobacillus reuteri ameliorates intestinal inflammation and modulates gut microbiota and metabolic disorders in dextran sulfate sodium-induced colitis in mice
Cheng et al. Targeting lung–gut axis for regulating pollution particle–mediated inflammation and metabolic disorders
Burakova et al. The effect of short-term consumption of lactic acid bacteria on the gut microbiota in obese people
Rysz et al. The impact of CKD on uremic toxins and gut microbiota
Qian et al. Bifidobacterium adolescentis is effective in relieving type 2 diabetes and may be related to its dominant core genome and gut microbiota modulation capacity
Infusino et al. Diet supplementation, probiotics, and nutraceuticals in SARS-CoV-2 infection: a scoping review
Tsao et al. Probiotic enhancement of antioxidant capacity and alterations of gut microbiota composition in 6-hydroxydopamin-induced Parkinson’s disease rats
Meng et al. Gut microbiota’s relationship with liver disease and role in hepatoprotection by dietary natural products and probiotics
Liu et al. Astaxanthin prevents alcoholic fatty liver disease by modulating mouse gut microbiota
Baek et al. Collagen peptide exerts an anti-obesity effect by influencing the firmicutes/bacteroidetes ratio in the gut
Zhao et al. High oleic acid peanut oil and extra virgin olive oil supplementation attenuate metabolic syndrome in rats by modulating the gut microbiota
Cabello-Olmo et al. A fermented food product containing lactic acid bacteria protects ZDF rats from the development of type 2 diabetes
Won et al. Lactobacillus sakei ADM14 induces anti-obesity effects and changes in gut microbiome in high-fat diet-induced obese mice
Ye et al. Lactobacillus plantarum-derived postbiotics ameliorate acute alcohol-induced liver injury by protecting cells from oxidative damage, improving lipid metabolism, and regulating intestinal microbiota
Yang et al. Isomaltulose exhibits prebiotic activity, and modulates gut microbiota, the production of short chain fatty acids, and secondary bile acids in rats
Zheng et al. Chinese propolis prevents obesity and metabolism syndromes induced by a high fat diet and accompanied by an altered gut microbiota structure in mice
Yang et al. Lactobacillus reuteri FYNLJ109L1 attenuating metabolic syndrome in mice via gut microbiota modulation and alleviating inflammation
Zhang et al. Fucoidan from Laminaria japonica ameliorates type 2 diabetes mellitus in association with modulation of gut microbiota and metabolites in streptozocin-treated mice
Qiu et al. GOS ameliorates nonalcoholic fatty liver disease induced by high fat and high sugar diet through lipid metabolism and intestinal microbes
Zhang et al. Mitigation of memory impairment with fermented fucoidan and λ-carrageenan supplementation through modulating the gut microbiota and their metagenome function in hippocampal amyloid-β infused rats
Kim et al. Lactiplantibacillus plantarum HY7718 improves intestinal integrity in a DSS-induced ulcerative colitis mouse model by suppressing inflammation through modulation of the gut microbiota
Guo et al. Mitigation of dextran-sodium-sulfate-induced colitis in mice through oral administration of microbiome-derived inosine and its underlying mechanisms
Liu et al. Reconfiguration of gut microbiota and reprogramming of liver metabolism with phycobiliproteins bioactive peptides to rehabilitate obese rats
Keshari et al. Skin cutibacterium acnes mediates fermentation to suppress the calcium phosphate-induced itching: a butyric acid derivative with potential for uremic pruritus
Hu et al. Phosphatidylserine from Portunus trituberculatus eggs alleviates insulin resistance and alters the gut microbiota in high-fat-diet-fed mice